HBOW
Latest round
- Angel
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 2
About HBOW
Established in 2021 and based in Shaoxing, China, HBOW is a fluorescence-targeted original new drug developer of drugs for intraoperative imaging of solid tumors. The Company has filed a Pre-IND application for a new drug during 2023. The Company focuses on the development of fluorescent-targeted contrast agents for intraoperative imaging of solid tumors to assist physicians in tumor resection procedures. The specific product is an infrared hypoxia-targeted contrast agent, NC527-X, which can be used for intraoperative real-time lesion-specific coloration of various solid tumors.
Who invested in HBOW
2 investors across 1 round
See all investors in HBOW
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jan 13, 2022
Amount
Undisclosed
Investors
Questions about HBOW
Who invested in HBOW?
HBOW has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HBOW raised?
HBOW has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HBOW last raise money?
HBOW's most recent round on record is a Angel, in Jan 2022.
What does HBOW do?
Established in 2021 and based in Shaoxing, China, HBOW is a fluorescence-targeted original new drug developer of drugs for intraoperative imaging of solid tumors.
Where is HBOW headquartered?
HBOW is headquartered in Shaoxing, China.
Which VCs invest in companies like HBOW?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at HBOW's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like HBOW? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.